SSRI & SSNRI
Antidepressants side-effects, neurological damage
Selective Serotonin / Nor-Epinehrine Re-Uptake Inhibitors
Go to
Introduction Antidepressants Negative personality, perception & physical
changes
Go to
Antidepressant Casualties in the Media Aggression, Homicide, Suicide &
Self-Harm
Go to Recent Media
Articles (SSRI) Antidepressants Pharmaceutical & FDA Fraud in 2004
Tardive Dyskinesia/Dystonia, Parkinsonism & Akathisia
SSRI & SSNRI antidepressants induced
side-effects (Iatrogenic Extrapyramidal Symptoms) are
recognized to be similar to Neuroleptic (anti-psychotic) induced side-effects.
These side-effects are known as Tardive Dyskinesia/Dystonia (severe body
movement disorder, mostly permanent), Parkinsonism (a sign of future
Parkinson's disease) and
Akathisia (a Neurological driven severe mania/agitation that can lead to
suicidality, suicide attempts, self-harm & suicide). It is well documented in
the medical literature that these neuroleptic induced side-effects refer to
damage at dopaminergic neurons in the "motor system" of the
"Basal
Ganglia", a structure deep in the "Limbic
System" of the brain.
1,
2,
3,
4,
http://www.emedicine.com/EMERG/topic338.htm (scroll down)
Serotonin Syndrome
The
Serotonin Syndrome is a potentially lethal condition
caused by excessive serotonergic activity. It is a very
dangerous and a potentially fatal side effect of the serotonergic
enhancing drugs such as SSRI & SSNRI antidepressants and is diagnosed by the
presence of at least 3 of 10 symptoms: mental status changes (confusion,
hypomania), agitation, myoclonus, hyperreflexia, diaphoresis, shivering, tremor,
diarrhea, incoordination, and fever. This "hyperserotonergic" toxic condition
requires heightened clinical awareness in order to prevent, recognize, and treat
the condition promptly. Promptness is vital because, as we just mentioned, the
serotonin syndrome can be fatal and death from this side effect
can come very rapidly. The Serotonin syndrome is brought on by excessive levels
of serotonin and is difficult to distinguish from the "Neuroleptic Malignant
Syndrome" because the symptoms are so similar. The "Neuroleptic Malignant
Syndrome" is a serious condition brought on by the use of neuroleptic drugs
(anti-psychotics).
Source: Prozac: Panacea or Pandora? by Dr Ann Blake Tracy
http://members.aol.com/atracyphd/syndrome.htm
Source: Journal of Clinical Psychiatry
Antidepressant induced neurological and/or physical toxicity (body
and/or brain damage) either as a result of prolonged inhibition of
P450-2D6 liver-enzymes, or as a result of impairing serotonin
metabolism, can take on many forms as described below. A few examples are:
Hyperserotonemia, such as the lifethreatening condition the Serotonin
Syndrome, Epileptiform Discharges, Epileptic Seizures and/or Epilepsy,
Hypoglycaemia/Hyperglycemia (Low/Elevated Blood Sugar Imbalance),
Stroke/Hemorrhagic Syndromes, Frontal Lobe Syndrome, Tardive
Dyskinesia/Dystonia, Parkinsonism, Akathisia, Mania,
etc...
MEDICAL REPORTS OF SSRI/SSNRI ANTIDEPRESSANT INDUCED
(IATROGENIC) SEVERE SYMPTOMS:
Go to:
Newborn Baby (Neonatal) Neurological Damage & Withdrawal
Go to:
General Physical & Mental Side-Effects
Go to:
Body Movement Disorders (Dystonia) & Parkinsonism (future Parkinson's
disease)
Go to:
Akathisia (neurological driven agitation), Mania & Restless Legs Syndrome
Go to:
Serotonin Syndrome, Neuroleptic Malignant Syndrome
Go to:
Blood/Organ Diseases, Stroke, Hemorrhage, TIA, Tumours & Bleedings
Go to:
Hepato Toxicity (Liver Damage)
Go to:
Cardiovascular Toxicity (Heart Damage) & Neurological Toxicity (Brain
Damage)
Go to:
Epileptiform Activity, Epilepsy, Seizures, REM Sleep/Memory/EEG Problems,
Sleepwalking
Go to:
Hypoglycemia (low blood sugar), Hyperglycemia (high blood sugar,
Diabetes)
Go to:
Urinary Incontinence, Dermatologic (Skin) Problems, Ocular (Eyes)
Disturbances
Go to:
Pain & Numbness, Swellings, Sexual (Organ) Problems, Hormonal Imbalances
Go to:
Hyponatremia & Syndrome of Inappropriate Secretion of Antidiuretic
Hormone (SIADH)
Go to:
(Suicide Overdose)-Toxicity & Death
Go to:
Suicide, Suicidality, Suicide Attempts & Self-Harm
Go to:
Mental State, Perceptual, Emotional & Psychological Changes
Go to:
Mental & Physical Side-Effects of Withdrawal/Discontinuation
Go to:
Other Observations & Complications: Case Reports, Reviews & Studies
Medical reports, side-effects: HYPOGLYCEMIA (Low
blood sugar), HYPERGLYCEMIA (High blood sugar, diabetes)
Medical reports: URINARY INCONTINENCE, DERMATOLOGIC
(Skin) PROBLEMS, OCULAR (Eyes) DISTURBANCES
Medical reports: PAIN & NUMBNESS, SWELLINGS, SEXUAL (ORGAN) PROBLEMS,
HORMONAL IMBALANCES
Medical reports, side-effects: HYPONATREMIA & SIADH
Medical reports, side-effects: SUICIDE, SUICIDALITY,
SUICIDE ATTEMTPS & SELF-HARM
| |
2004
|
09/14
|
FDA US |
|
Antidepressant "BLACK BOX WARNING" On Suicidality Risk Recommended
|
2004
|
08/26
|
FDA US |
|
New Warning Required: Antidepressants Induced
Suicide in Children & Adults
|
2004
|
08/20
|
FDA US |
|
FDA Update Review SSRI's: data suggestive of increased suicidality
risk
|
2004
|
06/08
|
HealthCanada |
|
ZYBAN WARNING: Risk of suicide, self-harm, behavioural/emotional
changes
|
2004
|
06/03
|
Health Canada |
|
Stronger warnings for SSRI's & other anti-depressants
|
2004
|
05/26
|
HealthCanada |
|
REMERON WARNING: Risk of suicide, self-harm, behavioural/emotional
changes
|
2004
|
05/26
|
HealthCanada |
|
ZOLOFT WARNING: Risk of suicide, self-harm, behavioural/emotional
changes
|
2004
|
05/26
|
HealthCanada |
|
CELEXA WARNING: Risk of suicide, self-harm, behavioural/emotional
changes
|
2004
|
05/26
|
HealthCanada |
|
EFFEXOR WARNING: Risk of suicide, self-harm, behavioural/emotional
changes
|
2004
|
05/18
|
HealthCanada |
|
PROZAC WARNING: Risk of suicide, self-harm, behavioural/emotional
changes
|
2004
|
05/18
|
HealthCanada |
|
PAXIL WARNING: Risk of suicide, self-harm, behavioural/emotional
changes
|
2004
|
04/23
|
EMEA/EUROPE |
|
CPMP/EMEA warning EUROPE: Paxil should not be used in children &
adolescents
|
2004
|
03/22
|
FDA US |
|
FDA: Cautions for Use of Antidepressants in
Adults & Children
|
2004
|
03/22
|
FDA US |
|
FDA: Worsening Depression & Suicidality with
Antidepressant Medications
|
2004
|
03/11
|
TGA AUS |
|
TGA: Use of SSRI antidepressants in children and adolescents
|
2004
|
02/03
|
FDA US |
|
Antidepressant Strengthened Warnings Pediatric Suicidality Risk
|
2003
|
00/00
|
Case/Review |
|
Paxil can cause some individuals to commit homicide and/or suicide
|
2003
|
12/10
|
MHRA/CSM UK |
|
SSRI antidepressants not for under 18 years in United Kingdom
/
MHRA site
|
2003
|
10/00
|
Case/Study |
|
Suicide Attempts in Clinical Trials with SSRI's in (MDD) Children
|
2003
|
09/00
|
Case/Review |
|
Antidepressants (SSRI's) and suicide: risk-benefit conundrums
|
2003
|
09/02
|
Case/Review |
|
Paxil: increased risk of suicidal thoughts, suicide attempts &
self-harm in children
|
2003
|
08/22
|
Wyeth |
|
Effexor/Efexor induces suicidal/homicidal behaviour in children
|
2003
|
06/15
|
Case/Review |
|
Paxil not for under 18-studies showing higher rates suicidal
thoughts & behaviour
|
2003
|
04/00
|
Case/Study |
|
Clinical Study Dr David Healy: Lines of evidence on Risks of suicide
with SSRIs
|
2001
|
03/00
|
Case/Study |
|
Treatment-Emergent Behavioural Side-Effects in adults with
learning disabilities
|
2001
|
01/00
|
No abstract |
|
PAXIL AND SELF-SCRATCHING
|
2000
|
06/13
|
Case/Study |
|
Occurrence of Deliberate Self-Harm highest with Fluoxetine
(Prozac/Sarafem)
|
2000
|
05/30
|
Clinical Trial |
|
Use of Sertraline (Zoloft) Linked to Suicidality
|
1999
|
12/00
|
Case/Review |
|
Deliberate Self-poisoning following Luvox/Fevarin-Neuroleptics
combination
|
1994
|
02/00
|
Case/Review |
|
Fluoxetine and Violent Death in Maryland: violent methods in
fluoxetine suicides
|
1995
|
00/00
|
Case/Review |
|
Fluoxetine: increased suicidal ideation and/or agitation have
been reported
|
1992
|
11/00
|
Case/Review |
|
Irritability, Self-Damage by Cutting & Violent Intense Suicidal,
Paranoid Ideation
|
1991
|
12/00
|
Case/Review |
|
Serious suicide attempts by 3 patients during treatment
Fluoxetine: Akathisia
|
1991
|
03/00
|
Case/Review |
|
Emergence of Self-destructive phenomena in children during Prozac
treatment
|
1990
|
02/00
|
Case/Review |
|
Emergence of Intense Suicidal Preoccupation during Prozac
(Sarafem) treatment
|
Medical reports, side-effects: MENTAL STATE, PERCEPTUAL, EMOTIONAL &
PSYCHOLOGICAL CHANGES
Medical reports, side-effects: MENTAL & PHYSICAL SIDE
EFFECTS OF WITHDRAWAL/DISCONTINUATION
Medical reports, side-effects: (SUICIDE
OVERDOSE)-TOXICITY & DEATH
OTHER OBSERVATIONS & COMPLICATIONS: CASE REPORTS, REVIEWS & STUDIES